Article
Idiotypic variation in a human B lymphoma cell line.
Journal of immunology (Baltimore, Md. : 1950) - 15 Jan 1990
Berinstein N, Campbell M J, Lam K, Carswell C, Levy S, Levy R
Abstract excerpt
The Ig Id of a B cell lymphoma serves as a distinct marker of the malignant clone and thus as a tumor-specific target for antibody therapy. Somatic variation of the Ig genes expressed by B cell tumors can lead to loss of reactivity with anti-Id antibodies and escape of tumors from the therapeutic effects of such antibodies. In our study, we have used anti-Id antibodies to screen for variants within a cell line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
